Arye Barak Ben

CIK: 0001917165

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NVCR

NovoCure Ltd

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

NVCR
NovoCure Ltd
Jun 30, 2026
Award(A)
Direct
1.3K shares at avg. $11.15$14K
NVCR
NovoCure Ltd
Mar 3, 2026
Award(A)
Direct
50.1K shares-
NVCR
NovoCure Ltd
Feb 28, 2026
Award(A)
Direct
17.8K shares-
NVCR
NovoCure Ltd
Dec 31, 2025
Award(A)
Direct
108 shares at avg. $10.99$1K
NVCR
NovoCure Ltd
Jun 30, 2025
Award(A)
Direct
769 shares at avg. $15.13$12K
NVCR
NovoCure Ltd
Mar 4, 2025
Award(A)
Direct
55K shares at avg. $18.19$1000K
NVCR
NovoCure Ltd
Dec 31, 2024
Award(A)
Direct
669 shares at avg. $14.75$10K

		Type	Shares	Price		Ownership
Jun 30, 2026	NVCR NovoCure Ltd	Award(A)	1,299	$11.15	$14,484	Direct
Mar 3, 2026	NVCR NovoCure Ltd	Award(A)	50,125	-	$0	Direct
Feb 28, 2026	NVCR NovoCure Ltd	Award(A)	17,755	-	$0	Direct
Dec 31, 2025	NVCR NovoCure Ltd	Award(A)	108	$10.99	$1,187	Direct
Jun 30, 2025	NVCR NovoCure Ltd	Award(A)	769	$15.13	$11,635	Direct
Mar 4, 2025	NVCR NovoCure Ltd	Award(A)	54,975	$18.19	$999,995	Direct
Dec 31, 2024	NVCR NovoCure Ltd	Award(A)	669	$14.75	$9,866	Direct

1-7 of 7 transactions

About Ben Arye Barak

Ben Arye Barak (SEC CIK 0001917165) files insider reports with the SEC as General Counsel of NovoCure Ltd (NVCR).

Signal8 holds 7 ownership filings by Ben Arye Barak (6 Form 4, 1 Form 5), filed between Jan 3, 2025 and Jul 1, 2026. Those filings report 7 transactions, from Dec 31, 2024 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ben Arye Barak's filings is in WAYNE, PA.

Recent filings by Ben Arye Barak

Jun 30, 2026: Grant or award of NVCR shares (Form 4, code A).
Mar 3, 2026: Grant or award of NVCR shares (Form 4, code A).
Feb 28, 2026: Grant or award of NVCR shares (Form 4, code A).
Dec 31, 2025: Grant or award of NVCR shares (Form 5, code A).
Jun 30, 2025: Grant or award of NVCR shares (Form 4, code A).

Other insiders filing for NovoCure Ltd (NVCR)

Puri Michal Nath, Chief Human Resources Officer
Leonard Frank X, Chief Executive Officer
Danziger Asaf, Director
LEUNG GABRIEL, Director
Stafford Kristin, Director
Ocean Allyson J, Director

How to read Form 4 transaction codes